קלרידקס

Country: Израел

Језик: Хебрејски

Извор: Ministry of Health

Активни састојак:

CLARITHROMYCIN

Доступно од:

DEXCEL LTD, ISRAEL

АТЦ код:

J01FA09

Фармацеутски облик:

קפליות

Састав:

CLARITHROMYCIN 250 MG

Пут администрације:

פומי

Тип рецептора:

מרשם נדרש

Произведен од:

DEXCEL LTD, ISRAEL

Терапеутска група:

CLARITHROMYCIN

Терапеутска област:

CLARITHROMYCIN

Терапеутске индикације:

Klaridex is indicated in the treatment of infections caused by one or more susceptible organisms. Indications include: Lower respiratory tract infections, for example, acute and chronic bronchitis and pneumonia. Upper respiratory tract infections, for example, sinusitis and pharyngitis. Klaridex is appropriate for initial therapy in community acquired respiratory infections and has been shown to be active in vitro against common and atypical respiratory pathogens as listed in the microbiology section. Klaridex is also indicated in skin and soft tissue infections of mild to moderate severity. Klaridex is also indicated in combination with proton pump inhibitor for the eradication of H. Pylori in patients with proven duodenal ulcer. Treatment of Mycobacterium Avium Complex infection in AIDS patients.

Датум одобрења:

2014-05-31